Kailera Therapeutics, Inc. Common Stock (KLRA) Live Share Price, Invest From India

Kailera Therapeutics, Inc. Common Stock Stock Performance

as on June 15, 2026 at 2:16 pm IST

Day's Low
Day's High
$18.69
Day's Price Range
$20.33
$18.89
1.06%
Downside
7.62%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$18.89
100.00%
Downside
-100.00%
Upside

Kailera Therapeutics, Inc. Common Stock share price movements today

Previous Close: $19.54
Open: $19.86
Volume: 548.4K
Day's Low - High: $18.69 - $20.33

Kailera Therapeutics, Inc. Common Stock Historical Returns

1 Month Return: -10.22 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Kailera Therapeutics, Inc. Common Stock Stock Fundamentals & Key Indicators

Check Kailera Therapeutics, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.4B

EPS (TTM)

-4.29

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-36.90%

Kailera Therapeutics, Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kailera Therapeutics, Inc. Common Stock with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Kailera Therapeutics, Inc. Common Stock	NA	$2.4B	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc	BUY	$37.8B	69.88%	70.89	12.55%	NA
Vertex Pharmaceuticals Inc	BUY	$112.9B	135.45%	26.39	35.51%	NA
Regeneron Pharmaceuticals Inc	BUY	$64.2B	16.05%	14.95	29.65%	0.59%

Indian Investors' Interest in Kailera Therapeutics, Inc. Common Stock Stock

Search interest for Kailera Therapeutics, Inc. Common Stock Stock has increased by 622% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 16, 2026 to June 15, 2026

Change:622% versus previous 30 day period

Kailera Therapeutics, Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2025	Mar 2026
Total Revenue	-	-
Gross Profit	-	-
Operating Income	-20	-84
EBITDA	-	-
Interest Expense	-	-
Depreciation	0	0
Income Before Tax	-17	-78
Income Tax Expense	-	-
Net Income	-17	-78
Net Profit Margin	0.00%	0.00%

Kailera Therapeutics, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

	Dec 2025
Total Revenue	-
Gross Profit	-
Operating Income	-158
EBITDA	-
Interest Expense	-
Depreciation	0
Income Before Tax	-148
Income Tax Expense	-
Net Income	-148
Net Profit Margin	0.00%

Kailera Therapeutics, Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

	Mar 2026
Net Income	-78
Operating Cash Flow	-68
Investing Cash Flow	-
Financing Cash Flow	-2
Change in Cash	-48

Insights on Kailera Therapeutics, Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 7 days, KLRA stock has moved down by -0.8%

About Kailera Therapeutics, Inc. Common Stock

Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions. The company develops clinical- and preclinical-stage therapies, with a product pipeline that includes injectable peptides, oral peptides, and oral small molecules. Key programs include KAI-9531, an injectable GLP-1/GIP receptor dual agonist; KAI-7535, an oral small molecule GLP-1 receptor agonist; and KAI-4729, an injectable GLP-1/GIP/glucagon receptor tri-agonist. Kailera Therapeutics holds exclusive rights for global development and commercialization of four metabolic disease assets outside of Greater China, with therapies delivered through oral and injectable formulations. The company was founded in 2024 and is based in Waltham, Massachusetts.

Organisation	Kailera Therapeutics, Inc. Common Stock
Headquarters	180 Third Avenue, Waltham, MA, United States, 02451
Industry	Biotechnology
CEO	Mr. Ronald C. Renaud Jr., M.B.A.
E-voting on shares	Click here to vote

Key Management of Kailera Therapeutics, Inc. Common Stock

Name	Title
Ms. Jamie Beth Coleman	Chief Commercial Officer
Mr. Douglas W. Pagan M.B.A.	Chief Financial Officer
Ms. Paula A. Cloghessy SHRM-SCP, SPHR	Chief People Officer
Dr. Scott M. Wasserman M.D.	Chief Medical Officer
Mr. Paul Douglas Burgess J.D., M.S.	Chief Operating & Business Officer
Maura Gavaghan	Vice President of Corporate Communications & Investor Relations
Mr. Scott M. Akamine J.D.	Chief Legal Officer & Secretary
Mr. Corey Manchester	Treasurer
Mr. Ronald C. Renaud Jr., M.B.A.	President, CEO & Director

FAQs

What is Kailera Therapeutics, Inc. Common Stock share price today?

Kailera Therapeutics, Inc. Common Stock share price today is $18.89 as on June 15, 2026 at 8:46 am IST at the close of the market. Kailera Therapeutics, Inc. Common Stock share today touched a day high of $20.33 and a low of $18.69.

What is the 52 week high and 52 week low for Kailera Therapeutics, Inc. Common Stock share?

Kailera Therapeutics, Inc. Common Stock share touched a 52 week high of $0 on January 1, 1970 and a 52 week low of $0 on January 1, 1970. Kailera Therapeutics, Inc. Common Stock stock price today i.e. June 15, 2026 at 8:46 am IST is closed at $18.89,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Kailera Therapeutics, Inc. Common Stock's market capitalisation today?

Kailera Therapeutics, Inc. Common Stock market capitalisation is $0.00T as on June 15, 2026 at 8:46 am IST.

How to invest in Kailera Therapeutics, Inc. Common Stock Stock (KLRA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Kailera Therapeutics, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kailera Therapeutics, Inc. Common Stock Shares that will get you 0.0794 shares as per Kailera Therapeutics, Inc. Common Stock share price of $18.89 per share as on June 15, 2026 at 8:46 am IST.

What is the minimum amount required to buy Kailera Therapeutics, Inc. Common Stock Stock (KLRA) from India?

Indian investors can start investing in Kailera Therapeutics, Inc. Common Stock (KLRA) shares with as little as ₹95.1 or $1 (as of June 15, 2026 at 2:47 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹951.00 in Kailera Therapeutics, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on June 15, 2026 at 2:47 pm IST). Based on Kailera Therapeutics, Inc. Common Stock share’s latest price of $18.89 as on June 15, 2026 at 8:46 am IST, you will get 0.5294 shares of Kailera Therapeutics, Inc. Common Stock. Learn more about fractional shares .